PMID- 22933232 OWN - NLM STAT- MEDLINE DCOM- 20130402 LR - 20161125 IS - 1529-0131 (Electronic) IS - 0004-3591 (Linking) VI - 64 IP - 12 DP - 2012 Dec TI - Stress-induced cartilage degradation does not depend on the NLRP3 inflammasome in human osteoarthritis and mouse models. PG - 3972-81 LID - 10.1002/art.34678 [doi] AB - OBJECTIVE: The main feature of osteoarthritis (OA) is degradation and loss of articular cartilage. Interleukin-1beta (IL-1beta) is thought to have a prominent role in shifting the metabolic balance toward degradation. IL-1beta is first synthesized as an inactive precursor that is cleaved to the secreted active form mainly in the "inflammasome," a complex of initiators (including NLRP3), adaptor molecule ASC, and caspase 1. The aim of this study was to clarify the roles of IL-1beta and the inflammasome in cartilage breakdown. METHODS: We assessed IL-1beta release by cartilage explants from 18 patients with OA. We also evaluated the lipopolysaccharide (LPS)-, IL-1alpha-, and tumor necrosis factor alpha (TNFalpha)-induced activity of matrix metalloproteinase 3 (MMP-3), MMP-9, and MMP-13 in NLRP3-knockout mice and wild-type mice and the inhibition of caspase 1 with Z-YVAD-FMK and the blockade of IL-1beta with IL-1 receptor antagonist (IL-1Ra). Cartilage explants from NLRP3-knockout mice and IL-1R type I (IL-1RI)-knockout mice were subjected to excessive dynamic compression (0.5 Hz, 1 MPa) to trigger degradation, followed by assessment of load-induced glycosaminoglycan (GAG) release and MMP enzymatic activity. RESULTS: Despite the expression of NLRP3, ASC, and caspase 1, OA cartilage was not able to produce active IL-1beta. LPS, IL-1alpha, and TNFalpha dose-dependently increased MMP-3, MMP-9, and MMP-13 activity in cultured chondrocytes and in NLRP3(-/-) chondrocytes, and this effect was not changed by inhibiting caspase 1 or IL-1beta. The load-induced increase in GAG release and MMP activity was not affected by knockout of NLRP3 or IL-1RI in cartilage explants. CONCLUSION: OA cartilage may be degraded independently of any inflammasome activity, which may explain, at least in part, the lack of effect of IL-1beta inhibitors observed in previous trials. CI - Copyright (c) 2012 by the American College of Rheumatology. FAU - Bougault, Carole AU - Bougault C AD - University Pierre and Marie Curie Paris VI, Paris, France. FAU - Gosset, Marjolaine AU - Gosset M FAU - Houard, Xavier AU - Houard X FAU - Salvat, Colette AU - Salvat C FAU - Godmann, Lars AU - Godmann L FAU - Pap, Thomas AU - Pap T FAU - Jacques, Claire AU - Jacques C FAU - Berenbaum, Francis AU - Berenbaum F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Arthritis Rheum JT - Arthritis and rheumatism JID - 0370605 RN - 0 (Carrier Proteins) RN - 0 (Inflammasomes) RN - 0 (Interleukin-1beta) RN - 0 (Lipopolysaccharides) RN - 0 (NLR Family, Pyrin Domain-Containing 3 Protein) RN - 0 (NLRP3 protein, human) RN - 0 (Nlrp3 protein, mouse) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.22.36 (Caspase 1) RN - EC 3.4.24.- (Matrix Metalloproteinases) SB - IM MH - Animals MH - Carrier Proteins/genetics/*physiology MH - Cartilage, Articular/*physiopathology MH - Caspase 1/metabolism MH - Cells, Cultured MH - Chondrocytes/drug effects/metabolism/pathology MH - Disease Models, Animal MH - Humans MH - Inflammasomes/*physiology MH - Interleukin-1beta/physiology MH - Lipopolysaccharides/pharmacology MH - Matrix Metalloproteinases/metabolism MH - Mice MH - Mice, Knockout MH - NLR Family, Pyrin Domain-Containing 3 Protein MH - Osteoarthritis, Knee/metabolism/*physiopathology MH - *Stress, Mechanical MH - Tumor Necrosis Factor-alpha/pharmacology EDAT- 2012/08/31 06:00 MHDA- 2013/04/03 06:00 CRDT- 2012/08/31 06:00 PHST- 2011/12/21 00:00 [received] PHST- 2012/08/14 00:00 [accepted] PHST- 2012/08/31 06:00 [entrez] PHST- 2012/08/31 06:00 [pubmed] PHST- 2013/04/03 06:00 [medline] AID - 10.1002/art.34678 [doi] PST - ppublish SO - Arthritis Rheum. 2012 Dec;64(12):3972-81. doi: 10.1002/art.34678.